1141774

WES Pharma Inc. — FEI 3010062344

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 28, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Westminster, MD (United States)

Additional Details

Risk Evaluation and Mitigation Strategies (REMS)